secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001493152-22-034493
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience issues $150,000 in demand promissory notes to CEO and entity controlled by CFO
--------------------------------------------------------------------------------

- $75,000 from CEO Steven Shum ($60,000 on Nov 29, $15,000 on Dec 2, 2022).
- $75,000 from Andax LLC, an entity controlled by CFO Andrea Goren, on Nov 29, 2022.
- Notes are interest-free if paid before Jan 31, 2023; otherwise 10% annual interest from issuance.
- At maturity, principal plus a 10% financing fee and accrued interest are payable.
- Notes callable with 10 days written notice starting 30 days from issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315222034493/0001493152-22-034493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315222034493/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-034493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer